Related references
Note: Only part of the references are listed.Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats
Vladimer Darsalia et al.
CLINICAL SCIENCE (2012)
Exenatide Alters Myocardial Glucose Transport and Uptake Depending on Insulin Resistance and Increases Myocardial Blood Flow in Patients with Type 2 Diabetes
M. Gejl et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Brain Imaging in Alzheimer Disease
Keith A. Johnson et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Effects of Insulin on Brain Glucose Metabolism in Impaired Glucose Tolerance
Jussi Hirvonen et al.
DIABETES (2011)
Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?
Christian Humpel
EXPERIMENTAL GERONTOLOGY (2011)
Targeting amyloid-beta by glucagon-like peptide-1 (GLP-1) in Alzheimer's disease and diabetes
Ann Mosegaard Bak et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Insulin for glycaemic control in acute ischaemic stroke
M. Fernanda Bellolio et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study
W. L. Xu et al.
DIABETOLOGIA (2009)
Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system
Alison Hamilton et al.
NEUROREPORT (2009)
Glucagon-like peptide-1 inhibits blood-brain glucose transfer in humans
Susanne Lerche et al.
DIABETES (2008)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus.: An [11C]-3-O-methyl-D-glucose PET study
EM Bingham et al.
DIABETOLOGIA (2005)
Aggregation of vascular risk factors and risk of incident Alzheimer disease
JA Luchsinger et al.
NEUROLOGY (2005)
Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis
K Morita et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Neurobarrier coupling in the brain: a partner of neurovascular and neurometabolic coupling?
L Leybaert
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Cerebral dysfunction in type 1 diabetes: effects of insulin, vascular risk factors and blood-glucose levels
AMA Brands et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Cerebral glucose metabolism in diabetes mellitus
AL McCall
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia
KB Degn et al.
DIABETES (2004)
Cerebral blood flow and metabolism during infusion of norepinephrine and propofol in patients with bacterial meningitis
K Moller et al.
STROKE (2004)
On the physiology of GIP and GLP-1
JJ Holst
HORMONE AND METABOLIC RESEARCH (2004)
Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system
PL Brubaker et al.
ENDOCRINOLOGY (2004)
The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans
ER Seaquist et al.
DIABETES (2001)
Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
NJ Morrish et al.
DIABETOLOGIA (2001)
Share Paper
